Papers

Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction

^a Coronary Care Unit, Green Lane Hospital, Auckland, New Zealand, ^b Coronary Care Unit, North Shore Hospital, Auckland, ^c Coronary Care Unit, Middlemore Hospital, Auckland, ^d Coronary Care Unit, Auckland Hospital, Auckland

Correspondence to: Dr John French, Cardiology Department, Green Lane Hospital, Epsom, Auckland 1003, New Zealand.

Abstract

Objective: To determine the proportion of patients presenting with acute myocardial infarction who are eligible for thrombolytic therapy.
Design: Cohort follow up study.
Setting: The four coronary care units in Auckland, New Zealand.
Subjects: All 3014 patients presenting to the units with suspected myocardial infarction in 1993.
Main outcome measures: Eligibility for reperfusion with thrombolytic therapy (presentation within 12 hours of the onset of ischaemic chest pain with ST elevation >/=2 mm in leads V1-V3, ST elevation >/=1 mm in any other two contiguous leads, or new left bundle branch block); proportions of (a) patients eligible for reperfusion and (b) patients with contraindications to thrombolysis; death (including causes); definite myocardial infarction.
Results: 948 patients had definite myocardial infarction, 124 probable myocardial infarction, and nine ST elevation but no infarction; 1274 patients had unstable angina and 659 chest pain of other causes. Of patients with definite or probable myocardial infarction, 576 (53.3%) were eligible for reperfusion, 39 had definite contraindications to thrombolysis (risk of bleeding). Hence 49.7% of patients (537/1081) were eligible for thrombolysis and 43.5% (470) received this treatment. Hospital mortality among patients eligible for reperfusion was 11.7% (55/470 cases) among those who received thrombolysis and 17.0% (18/106) among those who did not.
Conclusions: On current criteria about half of patients admitted to coronary care units with definite or probable myocardial infarction are eligible for thrombolytic therapy. Few eligible patients have definite contraindications to thrombolytic therapy. Mortality for all community admissions for myocardial infarction remains high.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    Twitter    What's this?

Relevant Article

Data on eligibility for thrombolytic treatment cannot be generalised

Adam D Timmis
BMJ 1996 313: 941. [Extract] [Full Text]

This article has been cited by other articles:

• (2005). Reperfusion in acute myocardial infarction. DTB 43: 49-53 [Abstract] [Full text]  
• Schomig, A., Mehilli, J., Antoniucci, D., Ndrepepa, G., Markwardt, C., Di Pede, F., Nekolla, S. G., Schlotterbeck, K., Schuhlen, H., Pache, J., Seyfarth, M., Martinoff, S., Benzer, W., Schmitt, C., Dirschinger, J., Schwaiger, M., Kastrati, A., for the Beyond 12 hours Reperfusion AlternatiVe Ev, (2005). Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial. JAMA 293: 2865-2872 [Abstract] [Full text]  
• Kastrati, A., Mehilli, J., Nekolla, S., Bollwein, H., Martinoff, S., Pache, J., Schuhlen, H., Seyfarth, M., Gawaz, M., Neumann, F.-J., Dirschinger, J., Schwaiger, M., Schomig, A., STOPAMI-3 Study Investigators, (2004). A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 43: 734-741 [Abstract] [Full text]  
• Cohen, M., Gensini, G. F., Maritz, F., Gurfinkel, E. P., Huber, K., Timerman, A., Krzeminska-Pakula, M., Santopinto, J., Hecquet, C., Vittori, L., on behalf of the TETAMI Investigators, (2003). Prospective Evaluation of Clinical Outcomes After Acute ST-Elevation Myocardial Infarction in Patients Who Are Ineligible for Reperfusion Therapy: Preliminary Results From the TETAMI Registry and Randomized Trial. Circulation 108: III-14-21 [Abstract] [Full text]  
• Schomig, A., Ndrepepa, G., Mehilli, J., Schwaiger, M., Schuhlen, H., Nekolla, S., Pache, J., Martinoff, S., Bollwein, H., Kastrati, A. (2003). Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis. Circulation 108: 1084-1088 [Abstract] [Full text]  
• Hyde, T A, French, J K, Wong, C-K, Edwards, C, Whitlock, R M L, White, H D (2003). Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes. Heart 89: 490-495 [Abstract] [Full text]  
• Wilkinson, J, Foo, K, Sekhri, N, Cooper, J, Suliman, A, Ranjadayalan, K, Timmis, A D (2002). Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction. Heart 88: 583-586 [Abstract] [Full text]  
• Wong, C.-K., French, J.K., Andrews, J., Frey, M.J., Adgey, A.A.J., Aylward, P.E., White, H.D. (2002). Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction. Eur Heart J 23: 399-404 [Abstract] [Full text]  
• Mehilli, J., Kastrati, A., Dirschinger, J., Pache, J., Seyfarth, M., Blasini, R., Hall, D., Neumann, F.-J., Schomig, A. (2002). Sex-Based Analysis of Outcome in Patients With Acute Myocardial Infarction Treated Predominantly With Percutaneous Coronary Intervention. JAMA 287: 210-215 [Abstract] [Full text]  
• Sayer, J W, Archbold, R A, Wilkinson, P, Ray, S, Ranjadayalan, K, Timmis, A D (2000). Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction. Heart 84: 258-261 [Abstract] [Full text]  
• Jacobs, A. K., French, J. K., Col, J., Sleeper, L. A., Slater, J. N., Carnendran, L., Boland, J., Jiang, X., LeJemtel, T., Hochman, J. S., for the SHOCK Investigators, (2000). Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1091-1096 [Abstract] [Full text]  
• Hourigan, C T, Mountain, D, Langton, P E, Jacobs, I G, Rogers, I R, Jelinek, G A, Thompson, P L (2000). Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time. Heart 84: 157-163 [Abstract] [Full text]  
• French, J. K., Hyde, T. A., Straznicky, I. T., Andrews, J., Lund, M., Amos, D. J., Zambanini, A., Ellis, C. J., Webber, B. J., McLaughlin, S. C., Whitlock, R. M. L., Manda, S. O. M., Patel, H., White, H. D. (2000). Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. J Am Coll Cardiol 35: 1516-1524 [Abstract] [Full text]  
• Capewell, S, Pell, J.P, Morrison, C, McMurray, J (1999). Increasing the impact of cardiological treatments. How best to reduce deaths. Eur Heart J 20: 1386-1392 [Abstract]  
• French, J. K., Hyde, T. A., Patel, H., Amos, D. J., McLaughlin, S. C., Webber, B. J., White, H. D. (1999). Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks. J Am Coll Cardiol 34: 62-69 [Abstract] [Full text]  
• Gottlieb, S., Boyko, V., Harpaz, D., Hod, H., Cohen, M., Mandelzweig, L., Khoury, Z., Stern, S., Behar, S., for the Israeli Thrombolytic Survey Group, (1999). Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. J Am Coll Cardiol 34: 70-82 [Abstract] [Full text]  
• Brown, N, Melville, M, Gray, D, Young, T, Skene, A M, Wilcox, R G, Hampton, J R (1999). Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis. Heart 81: 598-602 [Abstract] [Full text]  
• Mahon, N G, O'Rorke, C, Codd, M B, McCann, H A, McGarry, K, Sugrue, D D (1999). Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart 81: 478-482 [Abstract] [Full text]  
• French, J. K., Amos, D. J., Williams, B. F., Cross, D. B., Elliott, J. M., Hart, H. H., Williams, M. G., Norris, R. M., Ashton, N. G., Whitlock, R. M. L., McLaughlin, S. C., White, H. D. (1999). Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. J Am Coll Cardiol 33: 139-145 [Abstract] [Full text]  
• White, H. D., Van de Werf, F. J. J. (1998). Thrombolysis for Acute Myocardial Infarction. Circulation 97: 1632-1646 [Abstract] [Full text]  
• Barron, H. V., Bowlby, L. J., Breen, T., Rogers, W. J., Canto, J. G., Zhang, Y., Tiefenbrunn, A. J., Weaver, W. D. (1998). Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States : Data From the National Registry of Myocardial Infarction 2. Circulation 97: 1150-1156 [Abstract] [Full text]  
• Purcell, I F, Newall, N, Farrer, M (1997). Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes. Heart 78: 465-471 [Abstract] [Full text]  
• SMYTH, D. W, ELLIOTT, J. M (1997). Treating coronaries, at home or away?. Heart 78: 329-330 [Full text]  
• Timmis, A. D (1996). Data on eligibility for thrombolytic treatment cannot be generalised. BMJ 313: 941c-941 [Full text]  
• (1996). Eligibility for Thrombolysis. Journal Watch Cardiology 1996: 7-7 [Full text]